Compare PBLS & BFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PBLS | BFH |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.8B |
| IPO Year | 2026 | 2000 |
| Metric | PBLS | BFH |
|---|---|---|
| Price | $28.58 | $101.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 17 |
| Target Price | $41.40 | ★ $114.81 |
| AVG Volume (30 Days) | ★ 1.1M | 528.3K |
| Earning Date | 11-17-2026 | 10-22-2026 |
| Dividend Yield | N/A | ★ 0.97% |
| EPS Growth | N/A | ★ 98.36 |
| EPS | N/A | ★ 11.54 |
| Revenue | N/A | ★ $4,521,400,000.00 |
| Revenue This Year | N/A | $4.67 |
| Revenue Next Year | $300.17 | $3.23 |
| P/E Ratio | ★ N/A | $9.06 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.66 | $59.26 |
| 52 Week High | $42.49 | $114.53 |
| Indicator | PBLS | BFH |
|---|---|---|
| Relative Strength Index (RSI) | 49.52 | 49.08 |
| Support Level | $26.42 | $101.41 |
| Resistance Level | $41.72 | $108.99 |
| Average True Range (ATR) | 2.25 | 4.16 |
| MACD | 0.60 | 0.08 |
| Stochastic Oscillator | 71.30 | 35.69 |
Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.
Formed by a combination of JCPenney's credit card processing unit and The Limited's credit card bank business, Bread Financial is a provider of private-label and co-branded credit cards, loyalty programs, and marketing services. The company's most financially significant unit is its credit card business, which partners with retailers to jointly market Bread's credit cards to their customers. The company also retains a minority interest in spun-off LoyaltyOne, which operates the largest airline miles loyalty program in Canada and offers marketing services to grocery chains in Europe and Asia.